Ergoteles LLC Reata Pharmaceuticals Inc Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$30.85 - $93.17 $211,600 - $639,053	6,859 New	6,859 $623,000
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $220,769 - $415,037	11,374 New	11,374 $286,000
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $1.11 Million - $1.82 Million	-45,955 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $1.18 Million - $5.1 Million	45,955 New	45,955 $1.21 Million
Q4 2020 Feb 11, 2021	SELL	$102.03 - $184.62 $2.88 Million - $5.21 Million	-28,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $2.64 Million - $4.61 Million	28,200 New	28,200 $2.75 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.